Solvias AG


Solvias is a privately held company located in Kaiseraugst/Switzerland. With over 400 highly qualified employees, Solvias supports the research and development of new drug substances and the optimization of manufacturing processes for pharmaceutical, biotechnology and life science companies worldwide. Customers benefit from a wide range of experience in the following areas: Chemical development, process R&D, kilo-scale cGMP-API manufacturing, asymmetric synthesis, chiral ligands, HTS catalysis screening, CX-coupling, polymorph, salt and co-crystal screening, best form selection and crystallization optimization, comprehensive analytical services for small molcules and biologics, Process Analytical Technologies (PAT). All analytical services are cGMP-approved by the FDA and Swiss authorities.

More about Solvias
  • News

    Dr. Syuzanna R. Harutyunyan wins Solvias Ligand Contest

    The jury of the annual Solvias Ligand Contest awarded the 2011 prize to Dr. Syuzanna R. Harutyunyan, Assistant Professor in Synthetic Organic Chemistry at the University of Groningen. The Award Ceremony and presentation of the prize-winning contribution took place during the 10th Science Da ... more

    Solvias and RohnerChem announce partnership for custom research and manufacturing services

    Solvias and RohnerChem announced a partnership for custom research and manufacturing services. The preferred but non-exclusive partnership closes the chain of services from route scouting through to commercial manufacturing. Customers will benefit from the synergy of Solvias’ expertise in c ... more

    Solvias opens new Corporate Location

    Just in time for the New Year, the company relocated from Basel to Kaiseraugst. The new laboratories offer more space to provide the pharmaceutical and biopharmaceutical industry with the spectrum of services that includes analysis of large and small molecules, solid-state development, ... more